COMPARATIVE ANALYSIS OF THE COURSE OF THE DISEASE OF COVID-19 IN PATIENTS NOT VACCINATED AND VACCINATED WITH PFIZER-BIONTECH OR MODERNA

Authors

  • O. O. Kulyanda I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
  • O. S. Bilovus I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
  • R. I. Zaremba I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
  • O. V. Denefil I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

DOI:

https://doi.org/10.11603/1681-2786.2023.2.14029

Keywords:

vaccine, Pfizer-BioNTech, Moderna, health, COVID-19, complications

Abstract

Purpose: to evaluate the effect of vaccination with mRNA vaccines on the severity of the course for the disease of COVID-19, the level of hospitalization and distribution of virus.

Materials and Methods. The results of questionnaires and surveys of people were used in the study. The methods of comparative, systemic analyses were used.

Results. Our study included 1038 participants, of which 576 were vaccinated and 462 were unvaccinated. Among the vaccinated people, 21 had pneumonia, 18 had hypercoagulation, 34 had multiple organ failure, and 26 had post-COVID-19 syndrome.

Among unvaccinated people, 163 had pneumonia, 118 had hypercoagulation, 147 had multiple organ failure, and 197 had post-COVID-19 syndrome.

Conclusions. The effectiveness of the Pfizer-BioNTech vaccine had a major impact on the course of the pandemic. Vaccines stimulate the immune system and provoke the creation of highly specialized antibodies and the recruitment of T-killers, which counteract the massive replication of the virus, and therefore facilitate the clinical course of the disease and the presence of symptoms. In addition, it helped reduce transmission rates, providing protection against asymptomatic infections. This allowed countries to begin rebuilding their economies and protect people from serious complications of the disease.

Author Biographies

O. O. Kulyanda, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

PhD (Medicine), Associate Professor of the Department of Pathological Physiology, I. Horbachevsky Ternopil National Medical University

O. S. Bilovus, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

is a 3rd-year student of the I. Horbachevsky Ternopil National Medical University

R. I. Zaremba, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

is a 3rd-year student of the I. Horbachevsky Ternopil National Medical University

O. V. Denefil, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

DM (Medicine), Professor, Head of the department of pathological physiology, I. Horbachevsky Ternopil National Medical University

References

Karnik, M., Beeraka, N.M., Uthaiah, C.A., Nataraj, S.M., Bettadapura, A.D.S., Aliev, G., & Madhunapantula, S.V. (2021). A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development. Molecular Neurobiology. DOI 10.1007/s12035-021-02399-6. DOI: https://doi.org/10.1007/s12035-021-02399-6

Bourgonje, A.R., Abdulle, A.E., Timens, W., Hillebrands, J., Navis, G.J., Gordijn, S.J., … Goor, H. (2020). Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). The Journal of Pathology, 251(3), 228-248. DOI 10.1002/path.5471. DOI: https://doi.org/10.1002/path.5471

Zhang, H., Penninger, J.M., Li, Y., Zhong, N., & Slutsky, A.S. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46(4), 586-590. DOI 10.1007/s00134-020-05985-9. DOI: https://doi.org/10.1007/s00134-020-05985-9

Mazza, M.G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., … Benedetti, F. (2020). Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain, Behavior, and Immunity, 89, 594-600. DOI 10.1016/j.bbi.2020.07.037. DOI: https://doi.org/10.1016/j.bbi.2020.07.037

Soy, M., Keser, G., Atagündüz, P., Tabak, F., Atagündüz, I., & Kayhan, S. (2020). Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clinical Rheumatology, 39(7), 2085-2094. DOI 10.1007/s10067-020-05190-5. DOI: https://doi.org/10.1007/s10067-020-05190-5

Dal-Ré, R. (2021). US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine. Vaccine, 39(8), 1180-1182. DOI 10.1016/j.vaccine.2021.01.050. DOI: https://doi.org/10.1016/j.vaccine.2021.01.050

Tabassum, A., Iqbal, M.S., Sultan, S., Alhuthali, R.A., Alshubaili, D.I., Sayyam, R.S., … Arbaeen, A.F. (2022). Dysregulated Bradykinin: Mystery in the Pathogenesis of COVID-19. Mediators of Inflammation, 2022, 1-8. DOI 10.1155/2022/7423537. DOI: https://doi.org/10.1155/2022/7423537

Graña, C., Ghosn, L., Evrenoglou, T., Jarde, A., Minozzi, S., Bergman, H., ... Boutron, I. (2022). Efficacy and safety of COVID-19 vaccines. Cochrane Database of Systematic Reviews, 2022(12). DOI 10.1002/14651858.cd015477. DOI: https://doi.org/10.1002/14651858.CD015477

Explorons le code source du vaccin BioNTech / Pfizer contre le SARS-CoV-2. Retrieved from: https://renaudguerin.net/posts/explorons-le-code-source-du-vaccin-biontech-pfizer-sars-cov-2/.

Perico, L., Benigni, A., Casiraghi, F., Ng, L.F.P., Renia, L., & Remuzzi, G. (2020). Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nature Reviews Nephrology, 17(1), 46-64. DOI 10.1038/s41581-020-00357-4. DOI: https://doi.org/10.1038/s41581-020-00357-4

Iwasaki, A., & Omer, S.B. (2020). Why and How Vaccines Work. Cell, 183(2), 290-295. DOI 10.1016/j.cell.2020.09.040. DOI: https://doi.org/10.1016/j.cell.2020.09.040

Katella, K. (2021). Comparing the COVID-19 Vaccines: How Are They Different? Dental News, 28(1), 8-17. DOI 10.12816/0059056. DOI: https://doi.org/10.12816/0059056

Cantuti-Castelvetri, L., Ojha, R., Pedro, L.D., Djannatian, M., Franz, J., Kuivanen, S., … Simons, M. (2020). Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science, 370(6518), 856-860. DOI 10.1126/science.abd2985. DOI: https://doi.org/10.1126/science.abd2985

Saciuk, Y., Kertes, J., Mandel, M., Hemo, B., Shamir Stein, N., & Ekka Zohar, A. (2022). Pfizer-BioNTech vaccine effectiveness against Sars-Cov-2 infection: Findings from a large observational study in Israel. Preventive Medicine, 155, 106947. DOI 10.1016/j.ypmed.2021.106947. DOI: https://doi.org/10.1016/j.ypmed.2021.106947

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., … Pöhlmann, S. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181(2), 271-280.e8. DOI 10.1016/j.cell.2020.02.052. DOI: https://doi.org/10.1016/j.cell.2020.02.052

Semeraro, N., & Colucci, M. (2021). The prothrombotic state associated with sars-cov-2 infection: pathophysiological aspects. Mediterranean Journal of Hematology and Infectious Diseases, 13(1). DOI 10.4084/mjhid.2021.045. DOI: https://doi.org/10.4084/MJHID.2021.045

Okba, N.M.A., Müller, M.A., Li, W., Wang, C., GeurtsvanKessel, C.H., Corman, V.M., … Haagmans, B.L. (2020). Severe acute respiratory syndrome coronavirus 2−specific antibody responses in coronavirus disease patients. Emerging Infectious Diseases, 26(7), 1478-1488. DOI 10.3201/eid2607.200841. DOI: https://doi.org/10.3201/eid2607.200841

Qi, F., Qian, S., Zhang, S., & Zhang, Z. (2020). Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochemical and Biophysical Research Communications, 526(1), 135-140. DOI 10.1016/j.bbrc.2020.03.044. DOI: https://doi.org/10.1016/j.bbrc.2020.03.044

Xu, A., Hong, B., Lou, F., Wang, S., Li, W., Shafqat, A., … Fan, H. (2022). Sub-lineages of the SARS-CoV-2 Omicron variants: Characteristics and prevention. MedComm, 3(3). DOI 10.1002/mco2.172. DOI: https://doi.org/10.1002/mco2.172

Katawa, G., Tchopba, C.N., Tchadié, P.E., Simfele, C.H., Kamassa, E.H., Amessoudji, M.O., … Karou, S.D. (2021). Systematic Review on COVID-19 Vaccines: Comparative Study of AstraZeneca, Pfizer-BioNTech, Sputnik V, Johnson & Johnson, Moderna and Corona Vac. International Journal of Innovative Research in Medical Science, 6(11), 784-794. DOI 10.23958/ijirms/vol06-i11/1250. DOI: https://doi.org/10.23958/ijirms/vol06-i11/1250

Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020). The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European Journal of Internal Medicine, 76, 14-20. DOI 10.1016/j.ejim.2020.04.037. DOI: https://doi.org/10.1016/j.ejim.2020.04.037

Veluswamy, P., Wacker, M., Stavridis, D., Reichel, T., Schmidt, H., Scherner, M., … Michels, G. (2021). The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications. Viruses, 13(7), 1346. DOI 10.3390/v13071346. DOI: https://doi.org/10.3390/v13071346

Wilson, B., & Geetha, K.M. (2022). Lipid nanoparticles in the development of mRNA vaccines for COVID-19. Journal of Drug Delivery Science and Technology, 74, 103553. DOI 10.1016/j.jddst.2022.103553. DOI: https://doi.org/10.1016/j.jddst.2022.103553

Published

2023-08-24

How to Cite

Kulyanda, O. O., Bilovus, O. S., Zaremba, R. I., & Denefil, O. V. (2023). COMPARATIVE ANALYSIS OF THE COURSE OF THE DISEASE OF COVID-19 IN PATIENTS NOT VACCINATED AND VACCINATED WITH PFIZER-BIONTECH OR MODERNA. Bulletin of Social Hygiene and Health Protection Organization of Ukraine, (2), 12–19. https://doi.org/10.11603/1681-2786.2023.2.14029

Issue

Section

Health and society